We have identified a more suitable language of this document. To change language to please click here or close
We have identified a more suitable language of this document. To change language to please click here or close
We have detected you are using an older version of Internet Explorer that could cause visual issues on our website. Please update to the latest version, or switch to another browser for an optimal experience.
We would like to use cookies that will enable us to analyse the use of our websites and to personalise the content for you. If you agree to this, please click "Accept all" below. If you want to individually select which cookies we can set, please click "Select preferences" below. If you want to update your choices later or for more information, visit our Cookie Notice.
This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Privacy Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button "Update Cookie Preferences" in our Cookie Notice.
Technical cookies (required)
Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
Analytics cookies
Analytics cookies collect anonymised information such as the number of site visitors or most popular pages. These cookies “remember” that you have visited a website and this information may be shared with the providers of analytics services (see details in our privacy policy). Keeping these cookies enabled helps us improve our website and provide you with the most relevant content.
Personalisation cookies
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
Social media cookies
Social Media cookies collect information about you sharing information from our website via social media tools, or analytics to understand your browsing between social media tools or our Social Media campaigns and our own websites. We do this to optimise the mix of channels to provide you with our content. Details concerning the tools in use are in our privacy policy.
Welcome to ‘On the Pulse’ delivered by the Global Life Sciences & Healthcare Sector Group
A video/podcast series, On the Pulse, brings together CMS lawyers and experts to discuss key industry topics impacting, innovating and disrupting the life sciences & healthcare sector. The series is hosted by Nick Beckett, Global Co-Head of CMS Life Sciences & Healthcare Sector Group.
Subscribe, download, watch and listen to the CMS ‘On the Pulse’ videos here and podcasts here.
Video
New! Episode #4 – Digital Health – Part 2
In this final episode (Part 2), we discuss:
an increasing demand for digital health and increase in tele-consultations and use of chatbots
the digitalisation of healthcare records
the approach of Big Tech and their provision of advanced technical solutions
data privacy requirements regarding the use of immense data reserves in the provision of digital health services
the need to incorporate human insight and oversight into AI system processes
If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.
Episode #3 - Digital Health – Part 1
Nick Beckett discusses digital health with Rob Flaws (CMS Dubai), Niall McAlister (CMS UK) and Roland Wiring (CMS Germany).
In this episode (Part 1), we discuss:
the need for collaborations and to deal with a potential clash of cultures in bringing the “digital” and “health” sides of the industry together
the use of AI in track-and-trace and the search for a vaccine for COVID-19
the lack of clarity of the definition of AI
whether the EC White Paper sufficiently provides a comprehensive proposal for regulation of AI, and whether new legislation is required
where liability rests in respect of software
Episode #2 - Advertising of medicines and medical devices
Nick Beckett discusses with Dora Petranyi (CMS Hungary), Jens Wagner (CMS Germany) and Gabriela Staber (CMS Austria) the advertising of medicines and medical devices providing practical insights and an overview of the applicable laws.
In the episode, we consider:
the complicated and fast changing area of regulation of advertisements with different rules in different jurisdictions
how to verify that scientific evidence is sufficient to substantiate claims
the use of advertising in social media and other promotional campaigns
the approach of the authorities to new entrants to the market including in times of crisis
risks associated with competitors or consumer protection organisations filing claims
the potential impact of MDR on advertising of medical devices
Episode #1 – A legal roadmap for Cannabis
Nick Beckett discusses with Shuna Mason (CMS UK), Ellen Gielen (CMS Netherlands), Laura Opilio (CMS Italy) and how the medicinal cannabis industry is developing across Europe, the challenges it faces and what the future might hold. In particular, we discuss in this episode:
potentially the largest cannabis market on the planet;
how Moore’s law seems to apply to the legal opening up by authorities in Europe;
why there is yet to be significant use in practice;
what studies are needed to provide the hard scientific evidence healthcare professionals and authorities need to be comfortable with the efficacy and safety of medicinal cannabis;
whether recreational use in coffee shops may be diverted for medical use;
whether food supplements, cosmetics, drinks or even cigarettes could be an alternative means for patients to receive cannabis for medical purposes.
Managing Director of Lau, Horton & Wise LLP in Association with CMS Hasche Sigle, Hong Kong LLP and Global Co-Head of CMS Life Sciences & Healthcare Group
Social Media cookies collect information about you sharing information from our website via social media tools, or analytics to understand your browsing between social media tools or our Social Media campaigns and our own websites. We do this to optimise the mix of channels to provide you with our content. Details concerning the tools in use are in our privacy policy.